Skip to main content

Erynn Gordon

23andMe has appointed Erynn Gordon as its new medical marketing director. Gordon is the vice chair of the New Jersey Board of Medical Examiners’ genetic counseling advisory committee. At 23andMe she will lead engagement efforts with the medical community, as well as activities related to 23andMe's clinical applications.

She was previously the president of the American Board of Genetic Counseling and chaired the National Society of Genetic Counselors' ethics advisory board. Gordon will join 23andMe's commercial marketing group led by Ruby Gadelrab, VP of commercial marketing, and work with the medical affairs team led by 23andMe Chief Medical Officer Jill Hagenkord.

The Scan

And For Adolescents

The US Food and Drug Administration has authorized the Pfizer-BioNTech SARS-CoV-2 vaccine for children between the ages of 12 and 15 years old.

Also of Concern to WHO

The Wall Street Journal reports that the World Health Organization has classified the SARS-CoV-2 variant B.1.617 as a "variant of concern."

Test for Them All

The New York Times reports on the development of combined tests for SARS-CoV-2 and other viruses like influenza.

PNAS Papers on Oral Microbiome Evolution, Snake Toxins, Transcription Factor Binding

In PNAS this week: evolution of oral microbiomes among hominids, comparative genomic analysis of snake toxins, and more.